source
- Study finds stopping statins in older adults may lead to worse outcomes despite non-inferior labelA new trial called STREAM examined whether older adults without prior heart attacks or strokes could safely stop taking statins. The study was presented at the American Heart Association annual mee…
- BMS reports early Alzheimer’s psychosis data for Cobenfy showing reduced hallucinations but safety concerns remainAt the Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Boston, Bristol Myers Squibb presented early Phase 3 ADEPT data for KarXT, marketed as Cobenfy, in patients with Alzheimer’s disea…